Investors

International Investigative Dermatology (IID) Conference

May 16 - May 19, 2018

  • RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars

RXI-109:  sd-rxRNA targeting connective tissue growth factor (CTGF)
Date and Time: Thursday, May 17, 2018, 11:45 am – 1:45 p.m.
Session: Clinical Research, Pathophysiology and Therapeutics
Poster #: 496, Gatlin Ballroom

  • Samcyprone™ (diphenylcyclopropenone ointment) for the Treatment of Common Warts

Samcyprone:  small molecule, proprietary topical formulation of diphenylcyclopropenone (DPCP)
Date and Time: Friday, May 18, 2018, 12:00 pm – 2:00 p.m.
Session: Clinical Research, Pathophysiology and Therapeutics
Poster #: 490, Gatlin Ballroom
 

  • Topical Administration of self-delivering RNAi (sd-rxRNA) Compounds for the Reduction of Hyperpigmentation

RXI-231:  sd-rxRNA targeting tyrosinase (TYR)
Date and Time: Friday, May 18, 2018, 12:00 pm – 2:00 p.m.
Session: Pigmentation and Melanoma
Poster #: 1257, Gatlin Ballroom

Location

Rosen Shingle Creek Resort in Orlando, Florida

Investors